PTC vs STRO
PTC Inc (PTC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
PTC Inc (PTC) is a software - application company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PTC currently screens at market cap $21.11B and trailing P/E 48.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PTC and STRO stock pages for the full models.
Not investment advice.